The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The purpose of the CMC Strategy Forum Europe 2020 is to offer a blend of topics that characterize the challenges facing the biotechnology industry in the next decade…
Continuous Manufacturing is the future standard for solid oral dosage forms. The greater process understanding, and control is redefining how drugs are produced. The faster, more precise and reliable manufacturing approach is enabling accelerated development. The case study reviews how continuous manufacturing supports accelerated development programs in a globalized context. The format will allow for interactive Q&A.
KBI Biopharma is a leading contract development and manufacturing organization for the biopharmaceutical industry. We accelerate and optimize drug development and manufacturing programs for our client partners…
ICH Q12 “Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management” reached Step 4 during the last ICH meeting in Singapore in November 2019…